Tetracycline reduces the
plasma levels of
atovaquone by about 40%.
The manufacturers suggest that parasitaemia should be closely monitored in patients taking atovaquone/proguanil and
tetracycline. In the UK, they also say that
tetracycline should be given with caution to patients taking
atovaquone for Pneumocystis
pneumonia.